Three entities are at the centre of this controversy: The Brazilian government, Bharat Biotech and a Singapore-based company called Madison Biotech.
Castle staff hope the service will bring more people to the site in Romania's Carpathian mountains, where tourist numbers have plummeted since the start of the pandemic.
'Prevention plus vaccination is what is going to take us into better territory by September or October.'
'The deaths of the children in the Gambia would batter India's reputation as the developing world's pharmacy.'
Members of the Spanish army administered the vaccines to the squad and coaching staff
If booster shots are given on priority, the pace of vaccination may slow further. In the worst case scenario, the country will take till mid-March to vaccinate its entire adult population partially.
The study estimates that the risk of reinfection with the Omicron variant is 5.4 times greater than that of the Delta variant.
The technical advisory group will now meet on November 3 for a final assessment.
'Most Indian logistics firms do not have the facility to store and transport COVID-19 vaccine right now.'
As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
PHE estimates that the vaccination programme in England has prevented 22 million infections, around 52,600 hospitalisations and between 35,200 and 60,000 deaths.
Biden received the first course of the Pfizer-BioNTech vaccine at ChristianaCare Hospital in Newark, Delaware.
It will be unfair to put a date for any COVID wave as the behaviour of coronavirus is unpredictable and a disciplined and effective pandemic response can help the country get away from any significant outbreak, COVID Task Force chief V K Paul said.
While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.
If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval.
Gadot later deleted the Story, but the senior activist is still part of her post in the feed.
Serum Institute has the capacity to make 250 million doses of Covishield monthly.
Only half India's population has received the first shot of Covishield and Covaxin and the government's immediate task is to first vaccinate its adult population before placing its focus on children.
This means there are now four promising vaccines on the horizon after Pfizer-BioNTech, Sputnik and Moderna already reporting good preliminary data from Phase 3 trials.
The distribution of the Covid-19 vaccine is underway across the world. To provide a convenient and safe place for people to receive COVID-19 vaccines, countries around the world transform shopping malls, churches, airports, subway stations and museums to vaccination centers. Some also offer vaccination services on the river and mountain.
"There is no sufficient supply of vaccine vials by the Centre for inoculation of above-45 age group people. Hence, the state cabinet decided to divert the stock, purchased for the 18-44 age group, for the above-45 age group," Health Minister Rajesh Tope said.
Antibody levels are higher when people receive the COVID-19 vaccine in the afternoon as compared to the morning, according to an observational study.
In two days since its launch, an online campaign (https://www.change.org/p/cancel-the-tokyo-olympics-to-protect-our-lives-stoptokyoolympic) called "Stop Tokyo Olympics" has gathered over 210,000 signatures, exceeding its initial 200,000 goal.
The trial is being conducted in three phases by segregating children into categories according to their age. The first trial was started in the age group of 12 to 18 years followed by the age group of 6 to 12. Trials for children between the ages of and 2-6 years are currently undergoing trials.
Drug majors Pfizer and Abbott stopped sale of their popular cough syrups Corex and Phensedyl respectively.
There is confusion over the United Kingdom government's vaccine recognition process for Indian travellers as even though Oxford/AstraZeneca Covishield, the India-manufactured Oxford/AstraZeneca COVID-19 vaccine, is on an updated international travel advisory, India is not yet on a list of 17 approved countries.
'Our study shows a greater risk reduction for people who received an mRNA vaccine after having received a first dose of a vector-based, as compared to people having received the vector-based vaccine for both doses,' Nordstrom said.
Some vaccine frontrunners are in advanced stages of trial and could hit the market by early next year, making the task of securing "last mile connectivity" and ensuring that nothing goes wrong before the shot is administered more urgent.
Putting an end to the vaccine certification row, the UK on Thursday announced that Indians, fully vaccinated with Covishield vaccine, will no longer require to undergo quarantine on their arrival in Britain from October 11.
The Centre has also contacted five domestic and three multinational vaccine makers to understand how soon a candidate vaccine against Covid-19 will be ready.
As for Bharat Biotech, the Subject Expert Committee (SEC) on COVID-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.
The UK government is under increasing pressure on Monday to review its COVID-19 vaccine protocol in place for travellers from India, after its updated rules effective from next month failed to recognise Indian vaccines under an expanded list of countries.
According to an official statement, the FDA has determined that the Moderna COVID-19 vaccine has met the statutory criteria for issuance of an emergency use authorisation (EUA).
The Omicron variant was first detected in India in Bengaluru with two people testing positive for it comprising a South African national of Indian origin and a doctor.
Scientists have identified antibodies that neutralise Omicron and other variants of coronavirus by targeting areas that remain essentially unchanged as the virus mutates.
The approval comes a day after Sinopharm said its vaccine showed 79.34 per cent efficacy and a 99.52 per cent antibody-positive conversion rate in the interim results of the Phase III clinical trials.
Women who receive the mRNA COVID-19 vaccine during pregnancy pass high levels of antibodies to their babies, according to a study.
The New York Times on Tuesday said Covaxin works by teaching the immune system to make antibodies against the SARS-CoV-2 coronavirus. The antibodies attach to viral proteins, such as the so-called spike proteins that stud its surface.
According to the agency, fully vaccinated people do not need to wear masks during small, outdoor gatherings even if there's a mixture of vaccinated and unvaccinated people.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances